Blood Screening Market - Global Market Research 2015-2019

Blood Screening Market - Global Market Research 2015-2019

Category : Healthcare
Published On : October  2015
Pages : 74



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About blood screening 
Blood screening is a medical process where blood is scanned for testing of particular condition or disease. This procedure is commonly performed for HIV, pregnancy, cancer, and other screening. It provides vital information to the physician regarding the functioning of organs such as kidney, liver, and thyroid. The major blood tests that are extensively used for diagnosing diseases include erythrocyte sedimentation rate (ESR), full blood count (FBC), electrolyte test, karyotyping, enzyme-linked immunosorbent assay (ELISA), C-reactive protein, liver function test, and blood cholesterol test. The market for blood screening has witnessed numerous technological advances such as shift toward the first-generation ELISA to highly advanced NAAT testing, since its inception.

Technavio's analysts forecast the global blood screening market to grow at a CAGR of 9.31% over the period 2014-2019.

Covered in this report
The report covers the current scenario and the growth prospects of the global blood screening market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of instruments, assays/consumables, and services for the technologies such as NAAT and multiplexed real-time PCR

Technavio's report, Global Blood Screening Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, Latin America, MEA, and North America; it also covers the landscape of the global blood screening market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
• APAC
• Europe
• Latin America
• MEA
• North America 

Key vendors
• Abbott Diagnostics 
• bioMérieux 
• Grifols
• Roche Diagnostics 

Other prominent vendors
• Alere 
• BD
• Beckman Coulter 
• Bio-Rad Laboratories 
• Cepheid 
• Diamedix 
• DiaSorin
• Eiken Chemical 
• Elitech 
• Enzo Biochem 
• Fujirebio/Innogenetics
• Hologic
• Immunetics
• Lab21 
• Meridian Bioscience 
• OraSure 
• Ortho Clinical Diagnostics 
• Qiagen 
• SeraCare
• Siemens Healthcare Diagnostics 
• Thermo Fisher Scientific 
• Trinity Biotech 

Market driver
• Increase in number of blood donations 
• For a full, detailed list, view our report

Market challenge
• Limitation of closed system 
• For a full, detailed list, view our report

Market trend
• Adoption of NAAT
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 06: Market segmentation by technology
NAAT
Multiplexed real-time PCR

PART 07: Market segmentation by product
Assays and consumables
Instruments
Services

PART 08: Geographical segmentation
Blood screening systems market in Americas
Blood screening systems market in EMEA
Blood screening systems market in APAC

PART 09: Market drivers
Increase in blood donations
Awareness of blood safety
Advances in personalized medicine

PART 10: Impact of drivers

PART 11: Market challenges
Limitation of closed systems
Regulatory issues
Lack of skilled technicians
Complexity and low detection capability

PART 12: Impact of drivers and challenges

PART 13: Market trends
Implementation of NAAT
Initiatives in rare disease research
Strategic alliances
Advances in IT

PART 14: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 15: Key vendor analysis
Abbott Diagnostics
bioMérieux
Grifols
Roche Diagnostics

PART 16: Appendix
List of abbreviations

PART 17: Explore Technavio

List of Exhibits

Exhibit 01: Product offerings
Exhibit 02: Global blood screening systems market segmentation
Exhibit 03: Global blood screening systems market 2014-2019 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global blood screening systems market segmentation by technology
Exhibit 06: Global NAAT systems market segmentation by adoption 2014
Exhibit 07: Grifols: Global NAAT systems market share 2014
Exhibit 08: Grifols: NAAT systems market share in US 2014
Exhibit 09: Grifols: NAAT systems market share in APAC 2014
Exhibit 10: Roche Diagnostics and Grifols: Global NAAT systems market share 2014
Exhibit 11: Percentage share of products used for blood screening 2014
Exhibit 12: Comparison of NAAT systems for simultaneous detection of HIV, HCV (RNA), and HBV (DNA)
Exhibit 13: Global NAAT systems market 2014-2019 ($ billions)
Exhibit 14: Global multiplexed real-time PCR systems market 2014-2019 ($ billions)
Exhibit 15: Global blood screening systems market segmentation by technology 2014
Exhibit 16: Global blood screening systems market segmentation by technology 2019
Exhibit 17: Global blood screening systems market segmentation by technology 2014-2019
Exhibit 18: Global blood screening systems market segmentation by product
Exhibit 19: Global blood screening systems market segmentation by product 2014
Exhibit 20: Global blood screening systems market segmentation by geography 2014
Exhibit 21: Global blood screening systems market segmentation by geography 2019
Exhibit 22: Global blood screening systems market segmentation by geography 2014-2019
Exhibit 23: List of blood donation organizations in Americas
Exhibit 24: Blood screening systems market in Americas 2014-2019 ($ billions)
Exhibit 25: List of blood donation organizations in Europe
Exhibit 26: Number of healthcare facilities in Europe with NAAT systems
Exhibit 27: Application of NAAT systems in Europe
Exhibit 28: Blood screening systems market in EMEA 2014-2019 ($ billions)
Exhibit 29: List of blood donation organizations in APAC
Exhibit 30: Blood screening systems market in APAC 2014-2019 ($ billions)
Exhibit 31: Impact of drivers
Exhibit 32: Impact of drivers and challenges
Exhibit 33: NAATs for blood screening
Exhibit 34: Difference between NAAT and ELISA
Exhibit 35: Global blood screening systems market: Ranking of companies 2014
Exhibit 36: Grifols: Key takeaways
Exhibit 37: Roche Diagnostics: Key takeaways
Exhibit 38: Abbott Diagnostics: Key takeaways
Exhibit 39: bioMérieux: Key takeaways
Exhibit 40: Abbott Diagnostics: Key business offerings
Exhibit 41: bioMérieux: Clinical applications
Exhibit 42: Grifols: Business segmentation by revenue 2014
Exhibit 43: Grifols: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 44: Grifols: Geographical segmentation by revenue 2014

Enquiry Before Buy
image
Can´t read the image ? refresh here.